Stock 600276 JIANGSU HENGRUI MEDICINE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Jiangsu Hengrui Medicine Co., Ltd.

Equities

600276

CNE0000014W7

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
44.75 CNY +0.13% Intraday chart for Jiangsu Hengrui Medicine Co., Ltd. -3.72% -1.06%
08:57am Hengrui Grants Rights to Bain Capital-Backed Company for Anti-Diabetes Treatment MT
06:00am Hengrui Pharmaceuticals to Resubmit Marketing Application for Liver Cancer Drug Combination to US FDA MT

Evolution of the average Target Price on Jiangsu Hengrui Medicine Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

7397e50c31017c5245dccef7a5b3d4._Wj1dHOyQUAYRnU4Vx7s2ggm0XJy4T9K8_sHMZSg8UI.yxiGEDvKKHdbNhd0Ime7sDFsuBRFg3curLUySP71uzunEb8YBuMUEnIcGg~79ee7316b7474d44bca0459eaf75189c

Analyst Recommendations on Jiangsu Hengrui Medicine Co., Ltd.

Nomura Adjusts Jiangsu Hengrui Medicine’s Price Target to 51.12 Yuan From 49.24 Yuan, Keeps at Neutral MT
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 49.24 Yuan From 50.19 Yuan, Keeps at Neutral MT
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 50.19 Yuan From 46.30 Yuan, Keeps at Neutral MT
Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 46.30 Yuan From 41.29 Yuan, Keeps at Neutral MT
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 41.29 Yuan From 38.29 Yuan, Keeps at Neutral MT
Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 34.13 Yuan From 31.71 Yuan, Keeps at Neutral MT
Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 31.71 Yuan From 55.66 Yuan, Keeps at Neutral MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
44.75 CNY
Average target price
57.5 CNY
Spread / Average Target
+28.49%
High Price Target
120 CNY
Spread / Highest target
+168.16%
Low Price Target
40.1 CNY
Spread / Lowest Target
-10.39%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Jiangsu Hengrui Medicine Co., Ltd.

Nomura

Ratings for Jiangsu Hengrui Medicine Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 600276 Stock
  4. Consensus Jiangsu Hengrui Medicine Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW